Company and Stock Identity

How Siemens Healthineers Connects to the Public Market

Company structure
Public company
Market access
Direct listing: Frankfurt and Xetra: SHL.
Stock name
Siemens Healthineers AG
Ticker and exchange
Frankfurt and Xetra: SHL
Research focus
Separate AI-enabled equipment and software from the broader imaging, diagnostics, and Varian businesses, and use country-specific regulatory sources for individual product claims.

Siemens Healthineers is separately listed and remains majority owned by Siemens AG.

A current price is not available in the automated United States market snapshot. Use the named exchange or the company investor-relations page for current trading data.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... Siemens Healthineers Investor Relations ... Investor relations

Siemens Healthineers publishes third-quarter 2026 results

The investor hub published the company report, presentation, and analyst materials for its third quarter of fiscal 2026.

Why it matters: For a diversified public company, current filings are the place to test whether AI claims are visible in segment performance, orders, or strategy rather than only product marketing.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Imaging, diagnostics, cancer care, AI, software, clinical applications, regulatory affairs, field service, and product work.

Qualification signal: A global medical technology company hires across regulated product, clinical, engineering, and service roles. The required credential belongs to the job and country, not to healthcare AI as one field.

Check current roles at Siemens Healthineers. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
Primary use case
Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
Typical deployment
Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow

Evidence questions

  • Was the tool tested prospectively and independently on comparable equipment and patients?
  • What are sensitivity, specificity, false positive workload, and time-to-action effects?
  • How does performance vary by site, scanner, demographic subgroup, and disease prevalence?

Regulatory and workflow questions

  • Which FDA authorization covers the exact product version, modality, and intended use?
  • Who retains final clinical responsibility and how is disagreement with the AI handled?
  • What post-deployment monitoring and material update notification does the vendor provide?

Data and contract questions

  • Where are images and derived data processed and retained?
  • Which PACS, RIS, pathology, and EHR integrations are supported in production?
  • Can data be used for model improvement, and what controls govern secondary use?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources